wRatings and UTEK Corporation’s Strategos Identify Most Competitive Health Care Companies
June 25 2009 - 6:00AM
Business Wire
UTEK Corporation (NYSE-AMEX: UTK) (LSE-AIM: UTK), a leading
innovation services company, and The wRatings Corporation, an
independent stock research firm, announced today the results of
their annual Most Competitive Companies in Health Care Study. The
study was conducted in a collaborative effort between The wRatings
Corporation and Strategos, a strategic innovation consulting
division of UTEK. Major highlights from the study include Johnson
& Johnson (NYSE: JNJ) moving from #3 to #1 in 2009, followed by
Alcon (NYSE: ACL) and Eli Lilly (NYSE: LLY). The largest jump was
Cardinal Health (NYSE: CAH), rising from #83 to #12.
Scores from wRatings are a blend of how well companies meet
customer expectations while also generating economic profit. The
quarterly survey is conducted with a representative sample of US
consumers and business executives. The firm has been conducting the
surveys since 1999.
Sometimes recessions have a cleansing effect on companies. The
current recession has jolted health care in a positive direction in
terms of economic profit. Health care companies have doubled their
return on capital from 5.1% in 2003 to 10.8% in 2009, on a trailing
twelve month basis.
Gary A. Williams, Chief Executive Officer and Founder of
wRatings, said, �Sector rotation into many of these safety stocks
occurred a while ago. But in stark contrast to other sectors,
pricing power with health care customers remains on the upswing in
2009. So in these uncertain times, several health care stocks are
on track to continued growth. No doubt this sector will emerge from
the recession stronger than before.�
Peter Skarzynski, Managing Director of Strategos and Author of
Innovation to the Core (HBSP, 2008), notes, �As we saw newcomers
challenge and overtake incumbents, we are reminded that R&D
spending alone is no assurance for winning. Companies that can
successfully challenge industry orthodoxies and innovate at the
level of the business model have the best chance of thriving in
this turbulent time.�
All 111 companies in the study received a W Score�, where 100
equals the most competitive nationally.
HEALTH CARE INDUSTRY �
2009 RANK �
2008 RANK �
COMPANY �
W SCORE� Biotechnology 1 3 Genentech (NYSE:
DNA) 72.30 Drug Retail 1 2 Walgreens (NYSE: WAG) 72.45 HC
Distributors 1 3 Cardinal Health (NYSE: CAH) 80.70 HC Equipment 1
10 Varian Medical (NYSE: VAR) 90.05 HC Facilities 1 3 Health Mgmt.
Assoc. (NYSE: HMA) 53.60 HC Information 1 1 IMS Health (NYSE: RX)
72.50 HC Services 1 4 Covance Inc. (NYSE: CVD) 83.45 HC Suppliers 1
2 Alcon Inc. (NYSE: ACL) 92.70 Pharmaceutical OTC (Over The
Counter) 1 5 GlaxoSmithKline OTC (NYSE: GSK) 83.55 Pharmaceutical
Rx (Prescription) 1 2 J&J Rx (NYSE: JNJ) 92.85
The annual report and Top 20 list is available at
www.strategos.com or www.wratings.com/projections.php?s=925hc.
Full data is available to wRatings subscribers.
About UTEK Corporation
UTEK� is a leading innovation services company. UTEK�s services
enable clients to become stronger innovators, rapidly source
externally developed technologies, create value from their
intellectual property and gain foresight into marketplace and
technology developments that affect their business. Strategos is a
strategic innovation consulting division of UTEK. Strategos helps
clients innovate and grow by bringing innovation to their core
business and organization. UTEK is a business development company.
For more information about UTEK and Strategos, please visit its
websites at www.utekcorp.com and www.strategos.com.
About The wRatings Corporation
The wRatings Corporation is an independent stock research firm
based in metro Washington, DC. The company was founded by Harvard
Business Review author and persuasion expert, Gary A. Williams. He
and his team continually study consumer and executive buying
behavior to project the future earnings performance of companies.
Since 1999, their original set of leading indicators uses a common
framework to measure the competitive strength of companies. For
more information about wRatings, please visit its website at
www.wRatings.com.
Forward-Looking Statements
Certain matters discussed in this press release are
�forward-looking statements." These forward-looking statements can
generally be identified as such because the context of the
statement will include words, such as UTEK "expects," "should,"
"believes," "anticipates" or words of similar import. Such
forward-looking statements are subject to certain risks and
uncertainties, which could cause actual results to differ
materially from those currently anticipated. These factors are not
exhaustive. New factors, risks and uncertainties may emerge from
time to time that may affect the forward-looking statements made
herein. These forward-looking statements are only made as of the
date of this press release and UTEK does not undertake any
obligation to publicly update such forward-looking statements to
reflect subsequent events or circumstances. This press release
(when filed) will be available on the Company�s website
www.utekcorp.com.
Utek (AMEX:UTK)
Historical Stock Chart
From Oct 2024 to Nov 2024
Utek (AMEX:UTK)
Historical Stock Chart
From Nov 2023 to Nov 2024